TG Therapeutics Inc (TGTX)

Exchange
NASDAQ
Symbol
TGTX
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is headquartered in New York, New York.
Country
USA

Stock price

At close: September 2, 2025

  • Open
    29.37
  • High
    30.25
  • Low
    29.04
  • Close
    29.73
  • Volume
    2,016,440

Financial ratios

Dec 31, 2024